Research ArticleDrug Discovery and Translational Medicine
Evaluation of factor VIII polysialylation: Identification of a longer-acting experimental therapy in mice and monkeys
Helmut Glantschnig, Alexander Bauer, Karima Benamara, Michael Dockal, Veronika Ehrlich, Herbert Gritsch, Gerald Hobarth, Frank M Horling, Alexandra Kopic, Peter Leidenmuhler, Birgit M Reipert, Hanspeter Rottensteiner, Tanja Ruthsatz, Gerald Schrenk, Maria Schuster, Peter L Turecek, Alfred Weber, Martin Wolfsegger, Friedrich Scheiflinger and Werner Hollriegl
Journal of Pharmacology and Experimental Therapeutics July 31, 2019, jpet.119.260067; DOI: https://doi.org/10.1124/jpet.119.260067
Helmut Glantschnig
Baxalta Innovations GmbH, am member of the Takeda group of companies
Alexander Bauer
Baxalta Innovations GmbH, am member of the Takeda group of companies
Karima Benamara
Baxalta Innovations GmbH, am member of the Takeda group of companies
Michael Dockal
Baxalta Innovations GmbH, am member of the Takeda group of companies
Veronika Ehrlich
Baxalta Innovations GmbH, am member of the Takeda group of companies
Herbert Gritsch
Baxalta Innovations GmbH, am member of the Takeda group of companies
Gerald Hobarth
Baxalta Innovations GmbH, am member of the Takeda group of companies
Frank M Horling
Baxalta Innovations GmbH, am member of the Takeda group of companies
Alexandra Kopic
Baxalta Innovations GmbH, am member of the Takeda group of companies
Peter Leidenmuhler
Baxalta Innovations GmbH, am member of the Takeda group of companies
Birgit M Reipert
Baxalta Innovations GmbH, am member of the Takeda group of companies
Hanspeter Rottensteiner
Baxalta Innovations GmbH, am member of the Takeda group of companies
Tanja Ruthsatz
Baxalta Innovations GmbH, am member of the Takeda group of companies
Gerald Schrenk
Baxalta Innovations GmbH, am member of the Takeda group of companies
Maria Schuster
Baxalta Innovations GmbH, am member of the Takeda group of companies
Peter L Turecek
Baxalta Innovations GmbH, am member of the Takeda group of companies
Alfred Weber
Baxalta Innovations GmbH, am member of the Takeda group of companies
Martin Wolfsegger
Baxalta Innovations GmbH, am member of the Takeda group of companies
Friedrich Scheiflinger
Baxalta Innovations GmbH, am member of the Takeda group of companies
Werner Hollriegl
Baxalta Innovations GmbH, am member of the Takeda group of companies
Article Figures & Data
Additional Files
Data Supplement
- Supplemental Data -
Supplemental methods, results, 2 tables.
- Supplemental Data -
In this issue
Research ArticleDrug Discovery and Translational Medicine
Evaluation of factor VIII polysialylation: Identification of a longer-acting experimental therapy in mice and monkeys
Helmut Glantschnig, Alexander Bauer, Karima Benamara, Michael Dockal, Veronika Ehrlich, Herbert Gritsch, Gerald Hobarth, Frank M Horling, Alexandra Kopic, Peter Leidenmuhler, Birgit M Reipert, Hanspeter Rottensteiner, Tanja Ruthsatz, Gerald Schrenk, Maria Schuster, Peter L Turecek, Alfred Weber, Martin Wolfsegger, Friedrich Scheiflinger and Werner Hollriegl
Journal of Pharmacology and Experimental Therapeutics July 31, 2019, jpet.119.260067; DOI: https://doi.org/10.1124/jpet.119.260067
Research ArticleDrug Discovery and Translational Medicine
Evaluation of factor VIII polysialylation: Identification of a longer-acting experimental therapy in mice and monkeys
Helmut Glantschnig, Alexander Bauer, Karima Benamara, Michael Dockal, Veronika Ehrlich, Herbert Gritsch, Gerald Hobarth, Frank M Horling, Alexandra Kopic, Peter Leidenmuhler, Birgit M Reipert, Hanspeter Rottensteiner, Tanja Ruthsatz, Gerald Schrenk, Maria Schuster, Peter L Turecek, Alfred Weber, Martin Wolfsegger, Friedrich Scheiflinger and Werner Hollriegl
Journal of Pharmacology and Experimental Therapeutics July 31, 2019, jpet.119.260067; DOI: https://doi.org/10.1124/jpet.119.260067
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement